Psychiatric Morbidity and Quality of Life in Skin Diseases: A Comparison of Alopecia Areata and Psoriasis

Overview

Journal Ind Psychiatry J

Date 2016 May 24

PMID 27212814

Citations 20

Authors

Sagar B Karia

Avinash De Sousa

Nilesh Shah

Sushma Sonavane

Anup Bharati

Affiliations

Soon will be listed here.

Abstract

Background: Alopecia areata (AA) and psoriasis are associated with various psychiatric comorbidities. Both greatly affect the quality of life (QOL) of patients and psychiatric comorbidities can further worsen it. Thus there is need to recognise psychiatric comorbidities and treat them in these patients.

Aims: To determine the psychiatric morbidity and the QOL in these patients to study the factors affecting them.

Methodology: 50 patients each of psoriasis and AA were included. 50 people accompanying these patients served as control group. They were diagnosed for psychiatric disorders by clinical interview. Scales used were severity of alopecia tool for AA, psoriasis area and severity index for psoriasis, WHO-QOL scale, Hamilton Rating Scale for anxiety and depression.

Results: 22% and 38% patients in AA and psoriasis group respectively suffered from psychiatric disorder, depression was present in 18% and 24% of patients and 4% and 12% had anxiety disorders in respective groups. The control group had only 6% of psychiatric comorbidities. QOL scores had negative correlation with Hamilton-A, Hamilton-D and severity of psoriasis scores and they were statistically significant but not with severity of AA.

Conclusion: Thus AA and psoriasis patients had more prevalence of psychiatric comorbidities and it had bearing on their QOL.

Citing Articles

Quality of life and well-being of dermatology patients: Influence of associated anxiety and depression in relation to satisfaction of care.

Mohapatra P, Sahu P, Mohapatra A, Kar N Ind Psychiatry J. 2025; 33(2):275-280.

PMID: 39898064 PMC: 11784666. DOI: 10.4103/ipj.ipj_154_23.

Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample.

Faouel N, Ghariani N, Ben Haouala A, Maghfour S, Lahoual M, Mokni S Tunis Med. 2024; 102(10):659-663.

PMID: 39441152 PMC: 11574381. DOI: 10.62438/tunismed.v102i10.5119.

Estimation of depression, anxiety and serum cortisol in patients with oral lichen planus, leukoplakia and oral submucous fibrosis.

A N, Khan Y, Sharma D, Sharma N, Mehta R, Gupta S Bioinformation. 2024; 20(6):655-659.

PMID: 39131520 PMC: 11312328. DOI: 10.6026/973206300200655.

Global Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis.

Salari N, Heidarian P, Hosseinian-Far A, Babajani F, Mohammadi M J Prev (2022). 2024; 45(4):611-649.

PMID: 38822990 DOI: 10.1007/s10935-024-00784-0.

Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel.

Rudnicka L, Trzeciak M, Alpsoy E, Arenberger P, Alper S, Benakova N Front Med (Lausanne). 2024; 11:1353354.

PMID: 38741770 PMC: 11089289. DOI: 10.3389/fmed.2024.1353354.

References

Devrimci-Ozguven H, Kundakci T, Kumbasar H, Boyvat A . The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2001; 14(4):267-71. DOI: 10.1046/j.1468-3083.2000.00085.x. View

Chu S, Chen Y, Tseng W, Lin M, Chen T, Hwang C . Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol. 2011; 166(3):525-31. DOI: 10.1111/j.1365-2133.2011.10714.x. View

Sampogna F, Picardi A, Chren M, Melchi C, Pasquini P, Masini C . Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004; 66(4):620-4. DOI: 10.1097/01.psy.0000132869.96872.b2. View

Gelfand J, Feldman S, Stern R, Thomas J, Rolstad T, Margolis D . Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004; 51(5):704-8. DOI: 10.1016/j.jaad.2004.04.014. View

Koo J, Shellow W, Hallman C, Edwards J . Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol. 1994; 33(12):849-50. DOI: 10.1111/j.1365-4362.1994.tb01018.x. View

Weiss S, Kimball A, Liewehr D, Blauvelt A, Turner M, Emanuel E . Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002; 47(4):512-8. DOI: 10.1067/mjd.2002.122755. View

Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez M . Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol. 2003; 42(6):434-7. DOI: 10.1046/j.1365-4362.2003.01340.x. View

Fortune D, Richards H, Griffiths C . Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005; 23(4):681-94. DOI: 10.1016/j.det.2005.05.022. View

Jowett S, Ryan T . Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med. 1985; 20(4):425-9. DOI: 10.1016/0277-9536(85)90021-8. View

10.

Sampogna F, Sera F, Abeni D . Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol. 2004; 122(3):602-7. DOI: 10.1046/j.0022-202X.2003.09101.x. View

11.

Ghanizadeh A . Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008; 47(11):1118-20. DOI: 10.1111/j.1365-4632.2008.03743.x. View

12.

Olsen E, Hordinsky M, Price V, Roberts J, Shapiro J, Canfield D . Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004; 51(3):440-7. DOI: 10.1016/j.jaad.2003.09.032. View

13.

FREDRIKSSON T, Pettersson U . Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978; 157(4):238-44. DOI: 10.1159/000250839. View

14.

Mattoo S, Handa S, Kaur I, Gupta N, Malhotra R . Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol. 2001; 28(8):424-32. DOI: 10.1111/j.1346-8138.2001.tb00004.x. View

15.

Grahovac T, Ruzic K, Sepic-Grahovac D, Dadic-Hero E, Pavesic Radonja A . Depressive disorder and alopecia. Psychiatr Danub. 2010; 22(2):293-5. View

16.

Hariram P, Mosam A, Aboobaker J, Esterhuizen T . Quality of life in psoriasis patients in KwaZulu Natal, South Africa. Indian J Dermatol Venereol Leprol. 2011; 77(3):333-4. DOI: 10.4103/0378-6323.79716. View

17.

Kumar V, Mattoo S, Handa S . Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. Asian J Psychiatr. 2013; 6(2):151-6. DOI: 10.1016/j.ajp.2012.10.005. View

18.

Gaikwad R, Deshpande S, Raje S, Dhamdhere D, Ghate M . Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol. 2006; 72(1):37-40. DOI: 10.4103/0378-6323.19716. View

19.

Colon E, Popkin M, Callies A, Dessert N, Hordinsky M . Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry. 1991; 32(3):245-51. DOI: 10.1016/0010-440x(91)90045-e. View